Barclays upgraded shares of Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Free Report) to a strong sell rating in a research note issued to investors on Tuesday, Zacks.com reports.
Separately, Royal Bank of Canada raised Recordati Industria Chimica e Farmaceutica to a “hold” rating in a report on Monday, October 7th.
Read Our Latest Research Report on RCDTF
Recordati Industria Chimica e Farmaceutica Stock Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter. The firm had revenue of $622.00 million during the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Featured Stories
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- Canada Bond Market Holiday: How to Invest and Trade
- Monster and Celsius Energized: Which Stock Offers More Upside?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Sherwin-Williams Plunges Into Buying Opportunity: Time to Buy?
- Stock Dividend Cuts Happen Are You Ready?
- Wolverine World Wide Breaks Out – Will the 92% Rally Continue?
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.